Reconstruction of single cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition

Exploring the complexity of the epithelial-to-mesenchymal transition (EMT) unveils a diversity of potential cell fates; however, the exact timing and intricate mechanisms by which early cell states diverge into distinct EMT trajectories remain unclear. Studying these EMT trajectories through single cell RNA sequencing is challenging due to the necessity of sacrificing cells for each measurement. In this study, we employed optimal-transport (OT) analysis to reconstruct the past trajectories of different cell fates during TGF-beta-induced EMT in the MCF10A cell line. Our analysis revealed three distinct trajectories leading to low EMT, partial EMT, and high EMT states. Cells along partial EMT trajectory showed substantial variations in the EMT signature and exhibited pronounced stemness. Throughout this EMT trajectory, we observed a consistent downregulation of the EED and EZH2 genes. This finding was validated by recent inhibitor screens of EMT regulators and CRISPR screen studies. Moreover, we applied our analysis of early-phase differential gene expression to gene sets associated with stemness and proliferation, pinpointing ITGB4, LAMA3, and LAMB3 as genes differentially expressed in the initial stages of the partial versus high EMT trajectories. We also found that CENPF, CKS1B, and MKI67 showed significant upregulation in the high EMT trajectory. While the first group of genes aligns with findings from previous studies, our work uniquely pinpoints the precise timing of these upregulations. Finally, the latter group of genes represents newly identified regulators, shedding light on potential targets for modulating EMT trajectories. Significance Statement In our study, we investigated cellular trajectories during EMT using a time-series scRNAseq dataset. OT analysis was used to infer cell-to-cell connections from scRNAseq data, allowing us to predict cell linkages and overcome limitations of sequencing such as the need to sacrifice cells for each measurement. This approach allowed us to identify diverse EMT responses under uniform treatment, a significant advancement over previous studies limited by the static nature of scRNAseq data. Our analysis identified a broad set of genes involved in the EMT process, uncovering novel insights such as the upregulation of cell cycle genes in cells predisposed to a high EMT state and the enhancement of cell adhesion marker genes in cells veering towards a partial EMT state. This work enriches our understanding of the dynamic processes of EMT, showcasing the varied cellular fates within the same experimental setup.

[1]  Manuel Barcenas,et al.  Tipping points in epithelial-mesenchymal lineages from single cell transcriptomics data. , 2024, Biophysical journal.

[2]  Yutong Sha,et al.  Reconstructing growth and dynamic trajectories from single-cell transcriptomics data , 2023, Nat. Mac. Intell..

[3]  A. Schneeweiss,et al.  Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer. , 2023, Cell reports.

[4]  A. Feinberg,et al.  Epigenetics as a mediator of plasticity in cancer , 2023, Science.

[5]  A. Emili,et al.  Parallelized multidimensional analytic framework applied to mammary epithelial cells uncovers regulatory principles in EMT , 2023, Nature Communications.

[6]  M. Salvatore,et al.  Fibrosis , 2023, Journal of Translational Medicine.

[7]  G. Peltz,et al.  GSEApy: a comprehensive package for performing gene set enrichment analysis in Python , 2022, Bioinform..

[8]  M. Boldrini,et al.  Spatial profiling of chromatin accessibility in mouse and human tissues , 2022, Nature.

[9]  A. Regev,et al.  Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis , 2022, Nature Cell Biology.

[10]  S. Sant,et al.  P4HA2: A link between tumor-intrinsic hypoxia, partial EMT and collective migration , 2022, bioRxiv.

[11]  J. Weissman,et al.  Mapping Transcriptomic Vector Fields of Single Cells , 2022, Cell.

[12]  Yaxuan Yang,et al.  Epithelial-to-mesenchymal transition proceeds through directional destabilization of multidimensional attractor , 2021, bioRxiv.

[13]  Fabian J Theis,et al.  RNA velocity—current challenges and future perspectives , 2021, Molecular systems biology.

[14]  V. Varadarajan Indian , 2021, Keywords of Identity, Race, and Human Mobility in Early Modern England.

[15]  I. Tirosh,et al.  Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysis , 2021, Nature Communications.

[16]  K. Tomczak,et al.  Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing , 2021, Proceedings of the National Academy of Sciences.

[17]  R. Salehi,et al.  The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment , 2021, Cancer Cell International.

[18]  Gershon Wolansky,et al.  Optimal Transport , 2021 .

[19]  Q. Nie,et al.  Inference of Intercellular Communications and Multilayer Gene-Regulations of Epithelial–Mesenchymal Transition From Single-Cell Transcriptomic Data , 2021, Frontiers in Genetics.

[20]  Judith B. Zaugg,et al.  Integrative Single-Cell RNA-Seq and ATAC-Seq Analysis of Human Developmental Hematopoiesis , 2020, Cell stem cell.

[21]  Jeffrey T. Chang,et al.  EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures , 2020, British Journal of Cancer.

[22]  D. McClay,et al.  Developmental Single-cell transcriptomics in the Lytechinus variegatus Sea Urchin Embryo , 2020, bioRxiv.

[23]  S. Miriuka,et al.  Downregulation of E-cadherin in pluripotent stem cells triggers partial EMT , 2020, Scientific Reports.

[24]  B. Vanderhyden,et al.  Context specificity of the EMT transcriptional response , 2020, Nature Communications.

[25]  Daniel Ramirez,et al.  Toward Modeling Context-Specific EMT Regulatory Networks Using Temporal Single Cell RNA-Seq Data , 2020, Frontiers in Molecular Biosciences.

[26]  Allon M. Klein,et al.  Lineage tracing meets single-cell omics: opportunities and challenges , 2020, Nature Reviews Genetics.

[27]  Lior Pachter,et al.  Protein velocity and acceleration from single-cell multiomics experiments , 2020, Genome Biology.

[28]  Jason T. George,et al.  Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum , 2020, bioRxiv.

[29]  S. Axler Probability Measures , 2019, Graduate Texts in Mathematics.

[30]  Fabian J Theis,et al.  Generalizing RNA velocity to transient cell states through dynamical modeling , 2019, Nature Biotechnology.

[31]  Cole Trapnell,et al.  A pooled single-cell genetic screen identifies regulatory checkpoints in the continuum of the epithelial-to-mesenchymal transition , 2019, Nature Genetics.

[32]  Johannes L. Schönberger,et al.  SciPy 1.0: fundamental algorithms for scientific computing in Python , 2019, Nature Methods.

[33]  F. Lechin,et al.  Disorders , 2019, Hegel’s Anthropology.

[34]  Yvan Saeys,et al.  A comparison of single-cell trajectory inference methods , 2019, Nature Biotechnology.

[35]  M. Gut,et al.  Single cell RNA-seq identifies the origins of heterogeneity in efficient cell transdifferentiation and reprogramming , 2019, eLife.

[36]  P. Rigollet,et al.  Optimal-Transport Analysis of Single-Cell Gene Expression Identifies Developmental Trajectories in Reprogramming , 2019, Cell.

[37]  E. Ben-Jacob,et al.  Toward understanding cancer stem cell heterogeneity in the tumor microenvironment , 2018, Proceedings of the National Academy of Sciences.

[38]  Anton Simeonov,et al.  KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. , 2018, Cancer cell.

[39]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[40]  R. Weinberg,et al.  New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature Reviews Molecular Cell Biology.

[41]  J. Weinstein,et al.  Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer , 2018, bioRxiv.

[42]  J. Roche The Epithelial-to-Mesenchymal Transition in Cancer , 2018, Cancers.

[43]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[44]  François-Xavier Vialard,et al.  Scaling algorithms for unbalanced optimal transport problems , 2017, Math. Comput..

[45]  Xiao-Fan Wang,et al.  TGF-β Family Signaling in the Control of Cell Proliferation and Survival. , 2017, Cold Spring Harbor perspectives in biology.

[46]  R. Weinberg,et al.  Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells , 2017, Proceedings of the National Academy of Sciences.

[47]  A. Regev,et al.  Scaling single-cell genomics from phenomenology to mechanism , 2017, Nature.

[48]  Fabian J Theis,et al.  Diffusion pseudotime robustly reconstructs lineage branching , 2016, Nature Methods.

[49]  J. DeVries,et al.  Analysis , 2015, Journal of diabetes science and technology.

[50]  Laura Buttitta,et al.  How the cell cycle impacts chromatin architecture and influences cell fate , 2015, Front. Genet..

[51]  Eshel Ben-Jacob,et al.  Towards elucidating the connection between epithelial–mesenchymal transitions and stemness , 2014, Journal of The Royal Society Interface.

[52]  T. Tan,et al.  Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients , 2014, EMBO molecular medicine.

[53]  M. Jacomy,et al.  ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software , 2014, PloS one.

[54]  P. ten Dijke,et al.  Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer. , 2013, Trends in biochemical sciences.

[55]  L. Miele,et al.  Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. , 2013, Cancer letters.

[56]  Eshel Ben-Jacob,et al.  MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.

[57]  D. Weitz,et al.  Single-cell analysis and sorting using droplet-based microfluidics , 2013, Nature Protocols.

[58]  B. Zhou,et al.  Epithelial-mesenchymal Transition---A Hallmark of Breast Cancer Metastasis. , 2013, Cancer hallmarks.

[59]  B. Bao,et al.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. , 2012, Biochimica et biophysica acta.

[60]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[61]  Michael Peyton,et al.  An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.

[62]  P. Bitterman,et al.  Molecular targeted therapy in lung cancer. , 2012, Minnesota medicine.

[63]  C. Heldin,et al.  Regulation of EMT by TGFβ in cancer , 2012, FEBS letters.

[64]  J. Ferrell Bistability, Bifurcations, and Waddington's Epigenetic Landscape , 2012, Current Biology.

[65]  Oliver Distler,et al.  Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis , 2012, Nature Communications.

[66]  Michael K. Wendt,et al.  Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer , 2011, Molecular biology of the cell.

[67]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[68]  Hideaki Sugawara,et al.  The Sequence Read Archive , 2010, Nucleic Acids Res..

[69]  Xin Lu,et al.  Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis , 2010, Clinical Cancer Research.

[70]  N. Altorki,et al.  TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer , 2010, Proceedings of the National Academy of Sciences.

[71]  B. Nordenskjöld,et al.  Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer , 2009, British Journal of Cancer.

[72]  M. Katoh,et al.  FGFR2-related pathogenesis and FGFR2-targeted therapeutics (Review). , 2009, International journal of molecular medicine.

[73]  Simone Brabletz,et al.  E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer , 2009, Cancer and Metastasis Reviews.

[74]  C. Villani Optimal Transport: Old and New , 2008 .

[75]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[76]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[77]  J. McNamara Cancer Stem Cells , 2007, Methods in Molecular Biology.

[78]  G. Berx,et al.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. , 2006, Gastroenterology.

[79]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[80]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[81]  J. Raser,et al.  Noise in Gene Expression: Origins, Consequences, and Control , 2005, Science.

[82]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[83]  Guido Tarone,et al.  Positional control of cell fate through joint integrin/receptor protein kinase signaling. , 2003, Annual review of cell and developmental biology.

[84]  Kristian Helin,et al.  EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.

[85]  C. Stratakis,et al.  Protein Kinase A Signaling , 2002 .

[86]  J. Taipale,et al.  The Hedgehog and Wnt signalling pathways in cancer , 2001, Nature.

[87]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[88]  J. Slingerland,et al.  Transforming growth factor-β and breast cancer: Cell cycle arrest by transforming growth factor-β and its disruption in cancer , 2000, Breast Cancer Research.

[89]  L. Cantley,et al.  Phosphoinositide 3-kinase and the regulation of cell growth. , 1996, Biochimica et biophysica acta.

[90]  Y. Hirata Progression of cancer. , 1995, Medical hypotheses.

[91]  Alexia Nalewaik Challenges , 1991, Prehospital and Disaster Medicine.

[92]  Takuma Nemoto,et al.  Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer , 1989, Journal of surgical oncology.

[93]  P. Rousseeuw Silhouettes: a graphical aid to the interpretation and validation of cluster analysis , 1987 .

[94]  James W. Bawden,et al.  Transitions , 1984 .

[95]  R. Startup Migration , 1970, Encyclopedic Dictionary of Archaeology.

[96]  S. Treści,et al.  Transport Problems , 1925, Nature.

[97]  Michael L. Waskom,et al.  Seaborn: Statistical Data Visualization , 2021, J. Open Source Softw..

[98]  Professor Wolf H Fridman,et al.  Microenvironment , 2020, Encyclopedic Dictionary of Archaeology.

[99]  C. Waddington The strategy of the genes : a discussion of some aspects of theoretical biology , 2014 .

[100]  A. Al Moustafa,et al.  EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. , 2012, Frontiers in bioscience.

[101]  Wes McKinney,et al.  Data Structures for Statistical Computing in Python , 2010, SciPy.

[102]  Cédric Villani,et al.  Gradient flows I , 2009 .

[103]  L. Ambrosio,et al.  Gradient Flows: In Metric Spaces and in the Space of Probability Measures , 2005 .

[104]  M. Baron,et al.  Developmental Hematopoiesis , 2005, Methods in Molecular Medicine.

[105]  L. Allen Stem cells. , 2003, The New England journal of medicine.

[106]  W. Hahn,et al.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.

[107]  E. Hay An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[108]  Alex Wilson Review , 1990, Radiocarbon.

[109]  Fausto Chiesa,et al.  Metastasis , 1980, Developments in Oncology.